HCC CONNECT is an international group of experts in the field of hepatocellular carcinoma and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.

HCC CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the HCC CONNECT experts

What’s new from HCC CONNECT

conference-update Conference update
Oncology 
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024

interactive-patient-case Interactive patient case

Episode

2

of 2

episode
Oncology 
Advanced HCC: Treatment options for patients ineligible for IO

Explore treatment options, adverse event management and next steps in this interactive patient case

Experts
Prof. Sammy Saab
Endorsed by
Blue Faery Digestive Cancers Europe 5th anniversary
Global Liver Institute
  • clock 15 MIN
  • calendar Jan 2024

Educational programme supported by an Independent Educational Grant from Bayer.
interactive-patient-case Interactive patient case

Episode

1

of 2

episode
Oncology 
Advanced HCC: When to switch to 2nd line treatment

Explore treatment selection and optimal sequencing after progression on immunotherapy in an interactive patient case video

Experts
Dr Timon Vandamme
Endorsed by
Blue Faery Digestive Cancers Europe 5th anniversary
Global Liver Institute
  • clock 15 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023

Data from an Asia-Pacific patient and HCP survey

Experts
Prof. Chee-Kiat Tan
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Roche.
podcast Podcast

Episode

2

of 2

episode
Oncology 
A New Era in Treating Patients with Advanced HCC

2nd line treatment selection and the right time to switch

Experts
Prof. Dr Jeroen Dekervel, Dr Amit Singal
Endorsed by
Digestive Cancers Europe
Blue Faery Global Liver Institute
  • download Downloadable
    Resources
  • clock MIN
  • calendar Aug 2023

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning

Module

2

of 2

module
Oncology 
The Use of Immunotherapy in HCC

Module 2: In-depth Subgroup Analyses and Challenges

Experts
Prof. Dr Peter R. Galle, Dr Aiwu Ruth He
Endorsed by
AASLD
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
video Video

Episode

4

of 4

episode
Oncology 
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy

Episode 4: Panel Discussion and Summary

Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon Yoo
Endorsed by
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Educational Grant from Bayer